Trial Profile
A phase IV, multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of Sorafenib in patients with hepatocellular carcinoma after radiological progression [Estudio fase IV, multicéntrico, aleatorizado, doble-ciego, controlado frente a placebo, para evaluar la eficacia y seguridad de Sorafenib en pacientes con carcinoma hepatocelular avanzado con progresión radiológica].
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2013
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SOPRAC
- 19 Jul 2012 New trial record